Log In
Sign Up
Imatinib Mesylate
Indications
Chronic and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy
Dose/Application
400-800mg daily. [Doses of 400mg or 600 mg should be administered OD, whereas a dose of 800 mg should be administered as 400 mg BD].
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us